跳至主要内容
临床试验/NCT03762785
NCT03762785Unknown1 期

Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine in Preschool Children Undergoing Abdominal Cancer Surgery

Assiut University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2018年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
16
试验地点
1
主要终点
pharmacokinitics of dexmedetomidine

研究概览

简要总结

the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.

详细描述

Inhalation of nebulized drug is an alternative route of administration that is relatively easy to set up, does not require venpuncture, but is associated with high bioavailability of the administered drug. Information on the pharmacokinetics of dexmedetomidine in the pediatric population is very limited, especially in children. To the best of investigators knowledge, there are no published reports on the pharmacokinetics of nebulized dexmedetomidine in children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • child aged 2-7 years
  • ASA I or II
  • scheduled for abdominal surgery
  • with average weight, height, normal serum albumin

排除标准

  • patients with allergy to the study drug
  • patients with significant organ dysfunction
  • patients with cardiac arrhythmia
  • patients with congenital heart disease
  • use of psychotropic medication and mental retardation.

研究组 & 干预措施

nebulized dexmedetomidine 2ug/kg

Active Comparator

inhalation of dexmedetomidine in the dose of 2ug/kg by nebulization

干预措施: nebulized Dexmedetomidine (Drug)

nebulized dexmedetomidine 3ug/kg

Active Comparator

inhalation of dexmedetomidine in the dose of 3ug/kg by nebulization

干预措施: nebulized Dexmedetomidine (Drug)

结局指标

主要结局

pharmacokinitics of dexmedetomidine

时间窗: at the basline and after the end of nebuization of the drug at 5 minutes,15 minutes,30 minutes, 45 minutes, 60 minutes, 90 minutes and 120 minutes

serum level of dexmedetomidine

次要结局

  • sedation score(baseline and after end of the drug adminstration by 30 mininute)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shereen Mamdouh

lecturer of anesthesia, ICU and pain manegement

Assiut University

研究点 (1)

Loading locations...

相似试验